H2PPY2 (H2PPY2_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)

Integrator complex subunit 9 UniProtKBInterProInteractive Modelling

658 aa; Sequence (Fasta) ; 10 identical sequences: Homo sapiens: Q9NV88; Pan troglodytes: K7A7Y4, K7AGR9; Gorilla gorilla gorilla: G3SJ43; Sapajus apella: A0A6J3GUY3; Rhinopithecus roxellana: A0A2K6QYX8; Rhinopithecus bieti: A0AAJ7I3J8, A0A2K6LY46; Piliocolobus tephrosceles: A0A8C9I8T0; Cebus imitator: A0A2K5PCD3

Available Structures

13 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of Integrator-PP2A-SOSS-CTD post-termination complex Heteromer
I3LJR4; P30153; P67775; Q5TA45; Q68E01; Q6P9B9; Q75QN2; Q8N201; Q96HW7; Q96N11; Q96SY0; Q9BQ15; Q9H0H0; Q9NRY2; Q9NV88; Q9NVH2; Q9NVM9; Q9NVR2; Q9UL03;
1-658
100.0ZN;MN;
Structure of Integrator-PP2A complex Heteromer
P30153; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8N201; Q96HW7; Q96N11; Q96SY0; Q9H0H0; Q9NV88; Q9NVH2; Q9NVM9; Q9NVR2; Q9UL03;
1-658
100.0MN;ZN;
Structure of Integrator-PP2A bound to a paused RNA polymerase II-DSIF-NELF-nucleosome complex Heteromer
A0A287ADR4; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A8D0JYF1; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00267; P06899; P0C0S8; P30153; P60899; P62805; P67775; Q5TA45; Q6NXT2; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q96N11; Q96SY0; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9NVM9; Q9NVR2; Q9UL03;
1-658
100.010×ZN;MG;MN;
Structure of the Integrator cleavage module with extended INTS4 and rigid body docked INTS9/11 CTD Heteromer
Q5TA45; Q96HW7; Q9NV88;
1-658
100.0
The structure of INTAC-PEC complex Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00267; P18615; P24928; P30153; P60899; P63272; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9UL03;
1-658
100.010×ZN;MN;MG;
The structure of human Integrator-PP2A complex Heteromer
P30153; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8N201; Q96HW7; Q9H0H0; Q9NV88; Q9NVH2; Q9UL03;
5-658
100.0ZN;MN;
Structural basis of Integrator-mediated transcription regulation Heteromer
A0A0B8RVL1; A0A287ADR4; A0A481DF93; A0A4X1TRS6; A0A4X1VEK9; A0A7K6NXI9; A0A7M4DUC2; F1RKE4; I3LCB2; I3LJR4; I3LSI7; O00267; P30153; P60899; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9UL03;
1-556
100.0MG; 10×ZN;MN;
Structure of the Integrator cleavage module with INTS4/9/11 Heteromer
Q5TA45; Q96HW7; Q9NV88;
1-556
100.0
INTS9-INTS11-BRAT1-WDR73 complex Heteromer
Q5TA45; Q6P4I2; Q6PJG6; Q9NV88;
1-511
100.0ZN;
Integrator cleavage module assembly intermediate Heteromer
Q5TA45; Q6PJG6; Q96HW7; Q9NV88;
1-511
100.0ZN;
INTS9-INTS11-BRAT1 complex Heteromer
Q5TA45; Q6PJG6; Q9NV88;
1-507
100.0ZN;
Structure of the human INTS9-INTS11-BRAT1 complex Heteromer
Q5TA45; Q6PJG6; Q9NV88;
2-505
100.0ZN;
Crystal structure of human Integrator IntS9-IntS11 CTD complex Heteromer
Q5TA45; Q9NV88;
582-658
100

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8rbx.1.6monomer0.801-658
100.00